NITAG recommendations

An affidavit form is socialized to receive the 4th dose for people over 18 years of age who need to leave the country.  

Vaccination with the 3rd dose is from 12 years of age and the 4th dose from 30 years of age. 

It is recommended to pay more attention to patients with comorbidity to apply the 4th dose and even more so in the population over 60 years of age.  

It is applied 5 months after the third dose, and they will have to sign the Affidavit.  

A virtual page of questions and answers should be established for professionals and the public so that they can be informed in a faster and more direct way. It should be implemented with the communication area. 

Vaccination in children older than 6 months to 5 years will start with the Modern vaccine, its schedule is of two doses, both are effective and because they are fewer doses, their acceptability is assured.     

The immunization technical standard is in the process of being updated. 

Evidence and epidemiological data are being compiled to determine the inclusion of the Hepatitis A and meningococcal vaccine. Information should be requested from the MoH to make decisions. 

Vaccination of pediatric HIV 2.11 patients. 

Vaccination of pediatric HIV patients with meningococcal vaccine is being discussed, starting at 9 months of age, others starting at two years of age.  

 The Surveillance Directorate of the Ministry of Health will send information on cases under 5 years of age and the Immunization Directorate is requested to send information to the Argentinean Chancellery on the vaccination of children under 5 years of age with the Hepatitis A vaccine. 

The MoH is requested to provide information on the prevalence, incidence, and IgG for hepatitis A in the population from 3 to 5 years old in Peru. 

Most of them indicate the application of Meningococcal vaccine with Menactra A, C, Y and W-135. Analyze its application because there are only 30 cases in Peru, it is necessary to evaluate. 

The participation of a representative of the HIV Experts Committee will be requested for the next Ordinary Meeting, who will present the basis for the application of vaccines in HIV patients.  

For the application of male HPV, we will wait for the WHO declaration, which will probably be in August. From this, the vaccination strategies by age groups or according to the demographic profile will be discussed.   

For Hepatitis "A" vaccination, information is requested to MoH about the prevalence, incidence, and IgG hepatitis A in the population from 3 to 5 years old in Peru. 

The Committee of Experts will participate in the Regional Network of Experts Group of the Americas, represented by its president Dr. Eduardo Verne Martin.